The effects of açaí oil addition in tilapia diets on performance, hepatic energy metabolism enzymes and antioxidant responses

2020 ◽  
Vol 52 (1) ◽  
pp. 395-402
Author(s):  
Tânia C. Leite ◽  
Fernanda Picoli ◽  
Diogo de A. Lopes ◽  
Matheus D. Baldissera ◽  
Carine F. Souza ◽  
...  
2019 ◽  
Author(s):  
Min Pi ◽  
Fuyi Xu ◽  
Ruisong Ye ◽  
Satoru K. Nishimoto ◽  
Robert A. Kesterson ◽  
...  

Author(s):  
Mario Vailati-Riboni ◽  
Fernanda Batistel ◽  
Rainie R C S Yambao ◽  
Claudia Parys ◽  
Yuan-Xiang Pan ◽  
...  

Abstract Background Post-ruminal supply of Met during the periparturient period enhances production efficiency (feed conversion to milk) in dairy cows partly through alleviation of oxidant and inflammatory status. Whether alterations in hepatic one-carbon (major contributor of antioxidants) and/or energy-metabolism contribute to these beneficial effects is unknown. Objectives Investigate alterations in hepatic one-carbon and energy metabolism and associations with plasma amino acids (AA) and production efficiency in response to enhanced post-ruminal supply of Met. Methods Holstein cows (n = 30/group) were fed during the last 28 days of pregnancy a control diet (CON) or the control plus ethyl-cellulose rumen-protected methionine (MET; 0.9 g·kg−1 of dry matter intake). Plasma (n = 15/group) and liver tissue (n = 10/group) were collected throughout the periparturient period to evaluate AA profiles, activity of TCA cycle, and one-carbon metabolism via mRNA abundance, enzyme activity, and targeted metabolomics. Results Cows in MET had greater overall (27%, P = 0.027) plasma Met concentrations, but had similar total plasma AA concentrations. Although mRNA abundance of one-carbon metabolism enzymes did not differ, hepatic activity of cystathionine β-synthase (CBS) (51.2 vs. 44.4 mmol·h−1·mg−1 protein; P = 0.032) and concentration (19%, P = 0.048) of the cellular antioxidant glutathione were greater overall in MET. mRNA abundance of aconitase 2 and fumarate hydratase was greater overall (P = 0.049), and phosphoenolpyruvate carboxykinase 1 tended (P = 0.093) to be greater overall in cows fed MET. There was a tendency (P ≤ 0.093) for greater overall hepatic concentrations of malic acid, α-ketoglutaric acid, and isocitric acid in cows fed MET. Conclusions Greater activity of CBS in response to enhanced post-ruminal supply of Met likely contributes to alleviating oxidant status by increasing concentrations of glutathione. Hence, transsulfuration plays an important role in the observed improvements in production efficiency of dairy cows during the periparturient period.


1987 ◽  
Vol 19 (4) ◽  
pp. 200-206 ◽  
Author(s):  
A. Tanaka ◽  
M. Noguchi ◽  
T. Morimoto ◽  
Y. Taki ◽  
Y. Shimahara ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Lourival A. Silva ◽  
Marina C. Vinaud ◽  
Ana Maria Castro ◽  
Pedro Vítor L. Cravo ◽  
José Clecildo B. Bezerra

Leishmaniasis is a complex disease that affects mammals and is caused by approximately 20 distinct protozoa from the genusLeishmania. Leishmaniasis is an endemic disease that exerts a large socioeconomic impact on poor and developing countries. The current treatment for leishmaniasis is complex, expensive, and poorly efficacious. Thus, there is an urgent need to develop more selective, less expensive new drugs. The energy metabolism pathways ofLeishmaniainclude several interesting targets for specific inhibitors. In the present study, we sought to establish which energy metabolism enzymes inLeishmaniacould be targets for inhibitors that have already been approved for the treatment of other diseases. We were able to identify 94 genes and 93Leishmaniaenergy metabolism targets. Using each gene’s designation as a search criterion in the TriTrypDB database, we located the predicted peptide sequences, which in turn were used to interrogate the DrugBank, Therapeutic Target Database (TTD), and PubChem databases. We identified 44 putative targets of which 11 are predicted to be amenable to inhibition by drugs which have already been approved for use in humans for 11 of these targets. We propose that these drugs should be experimentally tested and potentially used in the treatment of leishmaniasis.


Cell Research ◽  
2007 ◽  
Vol 17 (8) ◽  
pp. 689-700 ◽  
Author(s):  
Xiao-Lan Chen ◽  
Gang Lu ◽  
Ying-Xia Gong ◽  
Liang-Cai Zhao ◽  
Jie Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document